BioCentury
ARTICLE | Company News

Endo, Jubilant Life Sciences deal

February 1, 2010 8:00 AM UTC

Jubilant's Jubilant Biosys Ltd. subsidiary and Endo added additional targets to a 2009 cancer drug discovery and development deal after Jubilant met an undisclosed preclinical milestone. Jubilant will...